|
1.
|
Kowalski LP: Lymph node metastasis as a
prognostic factor in laryngeal cancer. Rev Paul Med. 111:42–45.
1993.PubMed/NCBI
|
|
2.
|
Nakane Y, Okamura S, Masuya Y, Okumura S,
Akehira K and Hioki K: Incidence and prognosis of para-aortic lymph
node metastasis in gastric cancer. Hepatogastroenterology.
45:1901–1906. 1998.PubMed/NCBI
|
|
3.
|
Arai Y, Kanamaru H, Yoshimura K, Okubo K,
Kamoto T and Yoshida O: Incidence of lymph node metastasis and its
impact on long-term prognosis in clinically localized prostate
cancer. Int J Urol. 5:459–465. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Liotta LA, Kleinerman J and Saidel GM:
Quantitative relationships of intravascular tumor cells, tumor
vessels, and pulmonary metastases following tumor implantation.
Cancer Res. 34:997–1004. 1974.PubMed/NCBI
|
|
5.
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
6.
|
Gertler R, Rosenberg R, Fuehrer K, Dahm M,
Nekarda H and Siewert JR: Detection of circulating tumor cells in
blood using an optimized density gradient centrifugation. Recent
Results Cancer Res. 162:149–155. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Vona G, Sabile A, Louha M, et al:
Isolation by size of epithelial tumor cells: a new method for the
immunomorphological and molecular characterization of circulating
tumor cells. Am J Pathol. 156:57–63. 2000. View Article : Google Scholar
|
|
8.
|
Talasaz AH, Powell AA, Huber DE, et al:
Isolating highly enriched populations of circulating epithelial
cells and other rare cells from blood using a magnetic sweeper
device. Proc Natl Acad Sci USA. 106:3970–3975. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
He W, Wang H, Hartmann LC, Cheng JX and
Low PS: In vivo quantitation of rare circulating tumor cells by
multiphoton intravital flow cytometry. Proc Natl Acad Sci USA.
104:11760–11765. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Ito H, Kanda T, Nishimaki T, Sato H,
Nakagawa S and Hatakeyama K: Detection and quantification of
circulating tumor cells in patients with esophageal cancer by
real-time polymerase chain reaction. J Exp Clin Cancer Res.
23:455–464. 2004.PubMed/NCBI
|
|
11.
|
Honma H, Kanda T, Ito H, et al: Squamous
cell carcinoma-antigen messenger RNA level in peripheral blood
predicts recurrence after resection in patients with esophageal
squamous cell carcinoma. Surgery. 139:678–685. 2006. View Article : Google Scholar
|
|
12.
|
Nagrath S, Sequist LV, Maheswaran S, et
al: Isolation of rare circulating tumour cells in cancer patients
by microchip technology. Nature. 450:1235–1239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Cohen SJ, Punt CJ, Iannotti N, et al:
Relationship of circulating tumor cells to tumor response,
progression-free survival, and overall survival in patients with
metastatic colorectal cancer. J Clin Oncol. 26:3213–3221. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Riethdorf S, Fritsche H, Muller V, et al:
Detection of circulating tumor cells in peripheral blood of
patients with metastatic breast cancer: a validation study of the
CellSearch system. Clin Cancer Res. 13:920–928. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Davis JW, Nakanishi H, Kumar VS, et al:
Circulating tumor cells in peripheral blood samples from patients
with increased serum prostate specific antigen: initial results in
early prostate cancer. J Urol. 179:2187–2191. 2008. View Article : Google Scholar
|
|
16.
|
Hou JM, Greystoke A, Lancashire L, et al:
Evaluation of circulating tumor cells and serological cell death
biomarkers in small cell lung cancer patients undergoing
chemotherapy. Am J Pathol. 175:808–816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Ksiazkiewicz M, Markiewicz A and Zaczek
AJ: Epithelial-mesenchymal transition: a hallmark in metastasis
formation linking circulating tumor cells and cancer stem cells.
Pathobiology. 79:195–208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Gorges TM, Tinhofer I, Drosch M, Roese L,
Zollner TM, Krahn T and von Ahsen O: Circulating tumour cells
escape from EpCAM-based detection due to epithelial-to-mesenchymal
transition. BMC Cancer. 12:1782012. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Kim NW, Piatyszek MA, Prowse KR, et al:
Specific association of human telomerase activity with immortal
cells and cancer. Science. 266:2011–2015. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Blackburn EH: Telomere states and cell
fates. Nature. 408:53–56. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Fujiwara T, Kagawa S, Kishimoto H, et al:
Enhanced antitumor efficacy of telomerase-selective oncolytic
adenoviral agent OBP-401 with docetaxel: preclinical evaluation of
chemovirotherapy. Int J Cancer. 119:432–440. 2006. View Article : Google Scholar
|
|
22.
|
Ito H, Inoue H, Sando N, et al: Prognostic
impact of detecting viable circulating tumour cells in gastric
cancer patients using a telomerase-specific viral agent: a
prospective study. BMC Cancer. 12:3462012. View Article : Google Scholar
|
|
23.
|
Lin HK, Zheng S, Williams AJ, et al:
Portable filter-based microdevice for detection and
characterization of circulating tumor cells. Clin Cancer Res.
16:5011–5018. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Zheng S, Lin HK, Lu B, Williams A, Datar
R, Cote RJ and Tai YC: 3D microfilter device for viable circulating
tumor cell (CTC) enrichment from blood. Biomed Microdevices.
13:203–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Brabletz T, Hlubek F, Spaderna S,
Schmalhofer O, Hiendlmeyer E, Jung A and Kirchner T: Invasion and
metastasis in colorectal cancer: epithelial-mesenchymal transition,
mesenchymal-epithelial transition, stem cells and beta-catenin.
Cells Tissues Organs. 179:56–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Sobin LH, Gospodarowicz MK and Wittekind
C: International Union Against Cancer: TNM Classification of
Malignant Tumours. 7th edition. Chichester, West Sussex, UK;
Hoboken, NJ: Wiley-Blackwell; 2010
|
|
29.
|
Kim SJ, Masago A, Tamaki Y, et al: A novel
approach using telomerase-specific replication-selective adenovirus
for detection of circulating tumor cells in breast cancer patients.
Breast Cancer Res Treat. 128:765–773. 2011. View Article : Google Scholar
|
|
30.
|
Cristofanilli M, Budd GT, Ellis MJ, et al:
Circulating tumor cells, disease progression, and survival in
metastatic breast cancer. N Engl J Med. 351:781–791. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Moreno JG, Miller MC, Gross S, Allard WJ,
Gomella LG and Terstappen LW: Circulating tumor cells predict
survival in patients with metastatic prostate cancer. Urology.
65:713–718. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Krebs MG, Sloane R, Priest L, et al:
Evaluation and prognostic significance of circulating tumor cells
in patients with non-small-cell lung cancer. J Clin Oncol.
29:1556–1563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Katsumata K, Sumi T, Mori Y, Hisada M,
Tsuchida A and Aoki T: Detection and evaluation of epithelial cells
in the blood of colon cancer patients using RT-PCR. Int J Clin
Oncol. 11:385–389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Bonsing BA, Beerman H, Kuipers-Dijkshoorn
N, Fleuren GJ and Cornelisse CJ: High levels of DNA index
heterogeneity in advanced breast carcinomas. Evidence for DNA
ploidy differences between lymphatic and hematogenous metastases
Cancer. 71:382–391. 1993.PubMed/NCBI
|
|
35.
|
Klijanienko J, el-Naggar AK, de Braud F,
et al: Tumor vascularization, mitotic index, histopathologic grade,
and DNA ploidy in the assessment of 114 head and neck squamous cell
carcinomas. Cancer. 75:1649–1656. 1995. View Article : Google Scholar : PubMed/NCBI
|
